NOUL Co., Ltd.
Noul is a healthcare technology company focused on innovative diagnostic solutions to improve medical access and accelerate cancer conquest. Their miLab platform offers digital microscopy and AI-based diagnostic products for malaria, blood analysis, and cervical cancer. Noul aims to impact one billion lives globally by providing all-in-one digital diagnostic workflows that enhance accuracy and speed. The company has established global partnerships and supply contracts, including exclusive deals in the Middle East and Europe, and participates in international health projects. Noul is publicly listed on the KOSDAQ and has a strong R&D focus with multiple patents and certifications, positioning itself as a leader in blood and cancer diagnostics worldwide.
NOUL Co., Ltd.
Noul is a healthcare technology company focused on innovative diagnostic solutions to improve medical access and accelerate cancer conquest. Their miLab platform offers digital microscopy and AI-based diagnostic products for malaria, blood analysis, and cervical cancer. Noul aims to impact one billion lives globally by providing all-in-one digital diagnostic workflows that enhance accuracy and speed. The company has established global partnerships and supply contracts, including exclusive deals in the Middle East and Europe, and participates in international health projects. Noul is publicly listed on the KOSDAQ and has a strong R&D focus with multiple patents and certifications, positioning itself as a leader in blood and cancer diagnostics worldwide.